|
|
|
|
Oral Contraceptives Effective for Endometriosis-Related Dysmenorrhea
NEW YORK (Reuters Health) Nov 28 - Treatment with a low-dose oral contraceptive pill (OCP) can reduce dysmenorrhea and non-menstrual pain associated with endometriosis, according to a report in the November issue of Fertility and Sterility....
|
|
|
Oral Contraceptives Effective for Endometriosis-Related Dysmenorrhea
_ Oral Contraceptives Effective for Endometriosis-Related Dysmenorrhea.
|
|
|
Long-Term Management of Endometriosis
Latest Health News How the healthcare provider and patient can work together MONTVALE, N.J., Nov.20 /PRNewswire/ -- For women, chronic pelvic pain resulting from endometriosis represents a lifelong challenge to obtain and maintain pain...
|
|
|
Long-Term Management of Endometriosis
How the healthcare provider and patient can work together MONTVALE, N.J., Nov.20 /PRNewswire/ -- For women, chronic pelvic pain resulting from endometriosis represents a lifelong challenge to obtain and maintain pain relief. Long-term...
|
|
|
Dyschezia and Posterior Deep Infiltrating Endometriosis: Analysis of 360 Cases
Journal of Minimally Invasive Gynecology, 10/30/08 Journal of Assisted Reproduction and Genetics, 10/27/08 Southern Medical Journal, 10/16/08 Dyschezia and Posterior Deep Infiltrating Endometriosis: Analysis of 360 Cases.
|
|
|
Neurocrine Biosciences Reports Third Quarter 2008 Results
SAN DIEGO, Calif., Oct.28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended September 30, 2008. For the third quarter of 2008, the Company reported a net loss of $17.7...
|
|
|
Neurocrine Biosciences Reports Third Quarter 2008 Results
SAN DIEGO, Calif., Oct.28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended September 30, 2008. For the third quarter of 2008, the Company reported a net loss of $17.7...
|
|
|
Neurocrine Biosciences Reports Third Quarter 2008 Results
SAN DIEGO, Calif., Oct.28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended September 30, 2008. For the third quarter of 2008, the Company reported a net loss of $17.7...
|
|
|
Neurocrine Biosciences Reports Third Quarter 2008 Results
SAN DIEGO, Calif., Oct.28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the quarter ended September 30, 2008. For the third quarter of 2008, the Company reported a net...
|
|
|
Neurocrine Biosciences Reports Third Quarter 2008 Results
SAN DIEGO, Calif., Oct.28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the quarter ended September 30, 2008. For the third quarter of 2008, the Company reported a net...
|
